Kymera Therapeutics, Inc.
IRAK4 DEGRADERS AND USES THEREOF
Last updated:
Abstract:
The present invention relates to a method of treating autoimmune/autoinflammatory diseases and hematological malignancies in a subject.
Status:
Application
Type:
Utility
Filling date:
15 Feb 2022
Issue date:
1 Sep 2022